Fasting triglycerides, glucose, and a few calculated indices — from data most labs already collect — can flag metabolic strain years before it shows up as a diagnosis. Here's how to read them against longevity-optimal targets, not just the standard range.
Insulin resistance rarely shows up as one abnormal result. It shows up as a pattern across several values that are already sitting in a standard fasting panel: triglycerides, fasting glucose, and HDL-C. If fasting insulin was drawn, that adds another data point.
From those same numbers, a few things can be calculated without any additional blood draw: the triglyceride-to-HDL ratio, HOMA-IR (if insulin was measured), the TyG Index, and the Atherogenic Index of Plasma (AIP). None of these require a new test. They're a different way of reading data you may already have.
A "normal" lab result means you're inside the range used to flag disease. It doesn't necessarily mean your metabolic markers are sitting where they'd ideally be for long-term cardiovascular health. Both are useful — they're just answering different questions, so we show them separately rather than collapsing them into one number.
Triglycerides and fasting glucose have guideline-anchored thresholds (ESC/EAS, ADA). TyG, AIP, and TG:HDL don't — they're literature and practice reference ranges, useful as directional context, not a pass/fail grade. No professional society has issued a formal cutoff for either index. We display them the same way we display every marker: teal for "sitting at an optimal reference point," soft gold for "worth a closer look" — never a red flag, never a risk score.
When cells become less responsive to insulin, the liver changes how it packages and clears fat in the bloodstream. That shift tends to raise triglycerides, lower HDL-C, and push LDL toward smaller, denser particles that carry more ApoB per unit of cholesterol. That's also why someone can have an unremarkable LDL-C and still carry more atherogenic particles than the LDL-C number alone suggests — the same discordance discussed in our ApoB guide.
The guideline-anchored values above (triglycerides, fasting glucose) follow ESC/EAS lipid guidance and the ADA Standards of Care. The calculated indices rest on a smaller, more specific evidence base:
doi:10.1210/jc.2010-0288.doi:10.1016/s0009-9120(01)00263-6.Both are established, peer-reviewed indices — and both remain practice/literature reference ranges rather than society-issued diagnostic cutoffs. We treat them with the same discipline as HOMA-IR and TG:HDL: shown as one input among several, not a verdict on their own.
Triglycerides and glucose — and everything calculated from them — depend on a true fasting draw. A non-fasting sample makes TyG, AIP, and TG:HDL unreliable to interpret.
Insulin resistance is a recognized amplifier of the gap between LDL-C and ApoB. If your LDL-C looks reassuring, this is one reason ApoB can still tell a different story.
AIP's published reference tiers are derived in mmol/L. If your results are in mg/dL, triglycerides and HDL-C need converting before the ratio is calculated — our free check tool handles this automatically.
Metabolic patterns shift with age, and a family history of type 2 diabetes or early cardiovascular disease changes how much weight these reference points deserve in the bigger picture.
If your numbers land in the "worth a closer look" range, the starting point is almost always the same regardless of which specific marker flagged it: diet quality (particularly refined carbohydrate and added sugar intake), regular movement, and sleep — the same foundations covered in our longevity framework. These aren't a prescription; they're the conversation starters worth bringing to your next visit.
If lifestyle changes aren't enough on their own, your physician may discuss further evaluation or treatment options with you directly — that decision, and any medication class involved, is between you and your treating physician, not something a report can determine.
This is a reference-frame starting point, not a diagnosis. TyG, AIP, and the other calculated indices above are directional tools meant to inform a conversation, not replace clinical judgment. Your physician has access to your full history, exam findings, and additional context a lab panel can't capture — they decide what, if anything, changes based on these numbers.
A Standard report includes your extended cardiometabolic panel — read by a lipidologist against longevity-optimal targets, not just the standard range.
See report options